Crispr Therapeutics Ag (CRSP)

R&D Expenses

$64.95M

Quarterly · Period ending: · USD

CRSP logo

CRSP R&D Expenses

Latest reported$64.95M
CRSP Quarterly R&D Expenses ($1.16M → $64.95M)
High-resolution chart · PNG

CRSP r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
64,952,000
68,574,000
77,865,000
58,902,000
65,294,000
72,484,000
82,155,000
77,360,000
75,320,000
71,339,000
95,144,000
90,698,000
101,555,000
99,935,000
103,555,000
116,622,000
123,223,000
118,245,000
103,095,000
83,500,000
82,332,000
70,620,000
82,365,000
71,008,000
59,380,000
54,193,000
48,761,000
57,246,000
39,533,000
33,822,000
28,801,000
39,820,000
25,633,000
19,519,000
20,030,000
17,845,000
17,120,000
14,805,000
15,572,000
12,052,000
8,602,000
6,012,000
6,174,000
3,749,000
1,486,000
1,164,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.